IMAC (BACK) Competitors $1.21 +0.09 (+8.04%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends BACK vs. ATPC, VSEE, BGLC, ATIP, CMAX, ACON, NIVF, GBNHF, UPHL, and BTTXShould you be buying IMAC stock or one of its competitors? The main competitors of IMAC include Agape ATP (ATPC), Vsee Health (VSEE), BioNexus Gene Lab (BGLC), ATI Physical Therapy (ATIP), CareMax (CMAX), Aclarion (ACON), NewGenIvf Group (NIVF), Greenbrook TMS (GBNHF), UpHealth (UPHL), and Better Therapeutics (BTTX). These companies are all part of the "healthcare" industry. IMAC vs. Agape ATP Vsee Health BioNexus Gene Lab ATI Physical Therapy CareMax Aclarion NewGenIvf Group Greenbrook TMS UpHealth Better Therapeutics Agape ATP (NASDAQ:ATPC) and IMAC (NASDAQ:BACK) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, community ranking, media sentiment, risk and dividends. Does the MarketBeat Community favor ATPC or BACK? Agape ATP and IMAC both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAgape ATPN/AN/AIMACOutperform VotesNo VotesUnderperform Votes1100.00% Is ATPC or BACK more profitable? IMAC has a net margin of 0.00% compared to Agape ATP's net margin of -194.09%. IMAC's return on equity of 0.00% beat Agape ATP's return on equity.Company Net Margins Return on Equity Return on Assets Agape ATP-194.09% -74.71% -56.08% IMAC N/A N/A -205.29% Which has more risk & volatility, ATPC or BACK? Agape ATP has a beta of 2.21, suggesting that its stock price is 121% more volatile than the S&P 500. Comparatively, IMAC has a beta of 0.29, suggesting that its stock price is 71% less volatile than the S&P 500. Does the media refer more to ATPC or BACK? In the previous week, IMAC had 2 more articles in the media than Agape ATP. MarketBeat recorded 2 mentions for IMAC and 0 mentions for Agape ATP. IMAC's average media sentiment score of 0.46 beat Agape ATP's score of 0.00 indicating that IMAC is being referred to more favorably in the news media. Company Overall Sentiment Agape ATP Neutral IMAC Neutral Do insiders & institutionals believe in ATPC or BACK? 0.0% of Agape ATP shares are held by institutional investors. Comparatively, 5.8% of IMAC shares are held by institutional investors. 4.6% of IMAC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has preferable earnings & valuation, ATPC or BACK? Agape ATP has higher earnings, but lower revenue than IMAC. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgape ATP$1.35M4.27-$2.10M-$0.73-1.99IMAC$16.19M0.09-$9.42MN/AN/A SummaryIMAC beats Agape ATP on 7 of the 11 factors compared between the two stocks. Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Get IMAC News Delivered to You Automatically Sign up to receive the latest news and ratings for BACK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BACK vs. The Competition Export to ExcelMetricIMACSpecialty outpatient clinics IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.39M$1.52B$5.14B$9.08BDividend YieldN/A0.30%5.09%4.23%P/E RatioN/A4.1490.1317.20Price / Sales0.0916.291,117.09117.05Price / CashN/A8.1443.1037.85Price / Book-1.831.264.784.78Net Income-$9.42M$36.27M$120.31M$225.60M7 Day Performance-0.82%-5.98%-1.92%-1.23%1 Month Performance12.04%11.34%13.65%0.46%1 Year Performance-50.00%-50.71%28.34%15.24% IMAC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BACKIMACN/A$1.21+8.0%N/A-25.3%$1.39M$16.19M0.00180Earnings ReportNews CoverageATPCAgape ATPN/A$1.25-12.6%N/A-89.2%$4.99M$1.35M-1.7040Positive NewsGap DownVSEEVsee HealthN/A$1.31-12.1%N/AN/A$4.72M$6.38M0.00N/ANews CoverageBGLCBioNexus Gene LabN/A$0.26-0.5%N/A-59.5%$4.65M$9.26M0.0030Positive NewsGap UpATIPATI Physical Therapy0.0636 of 5 stars$0.73+11.8%N/A-61.3%$3.21M$741.86M-0.045,600Gap UpCMAXCareMax0.8649 of 5 stars$0.42-26.2%N/A-96.7%$1.61M$751.10M0.001,450Positive NewsGap DownACONAclarion1.8597 of 5 stars$0.10-1.4%$1.30+1,156.0%-97.0%$1.08M$49,289.000.007Gap DownNIVFNewGenIvf Group0.5038 of 5 stars$0.27-14.4%N/AN/A$1.01M$5.14M0.00N/AGap DownGBNHFGreenbrook TMSN/A$0.01-6.6%N/AN/A$465,000.00$73.79M-0.01430Gap DownUPHLUpHealthN/A$0.00flatN/A-99.8%$6,000.00$130M0.001,750Gap UpHigh Trading VolumeBTTXBetter TherapeuticsN/A$0.00flatN/A-99.9%$5,000.00N/A0.0040 Related Companies and Tools Related Companies Agape ATP Competitors Vsee Health Competitors BioNexus Gene Lab Competitors ATI Physical Therapy Competitors CareMax Competitors Aclarion Competitors NewGenIvf Group Competitors Greenbrook TMS Competitors UpHealth Competitors Better Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BACK) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMAC Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMAC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BACK Stock Alerts